Back to Agenda
Session 9: Use of Artificial Intelligence in Clinical Trial Transparency
Session Chair(s)
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
Session 9: Use of Artificial Intelligence in Clinical Trial Transparency
Speaker(s)
Leveraging AI Agents to Enhance Clinical Trial Transparency and Efficiency
Representative Invited
Xogene, United States
Patient and Public Perceptions on the Use of AI in Creating Clinical Trial Documents
Representative Invited
CISCRP, United States
Modernizing the BMS PLS process, accelerating with AI support
Representative Invited
Bristol-Myers Squibb, United States
Have an account?